Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:03 29/06/2024 am IST			5-day change	1st Jan Change
183 ^USD	-1.16%		-1.01%	-4.94%

19/06	Vita Global Sciences Partners with Veeva Systems Inc. to Streamline Clinical Data Management	CI
13/06	Truist Securities Cuts Price Target on Veeva Systems to $197 From $203, Maintains Hold Rating	MT

Veeva Systems : to Present at the J.P. Morgan Healthcare Conference

January 12, 2016 at 03:22 am IST

Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced that Matt Wallach, President and Co-founder, will present at the J.P. Morgan Healthcare Conference on Thursday, January 14, 2016, at 8:30 a.m. Pacific time in San Francisco, CA.

The presentation will be webcast. Links to the live and archived webcast will be available on Veeva’s investor relations website at ir.veeva.com.

About Veeva Systems

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 375 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160111006562/en/

Latest news about Veeva Systems Inc.

Vita Global Sciences Partners with Veeva Systems Inc. to Streamline Clinical Data Management	19/06	CI
Truist Securities Cuts Price Target on Veeva Systems to $197 From $203, Maintains Hold Rating	13/06	MT
Veeva Systems Insider Sold Shares Worth $2,764,931, According to a Recent SEC Filing	08/06	MT
Transcript : Veeva Systems Inc. Presents at Baird 2024 Global Consumer, Technology & Services Conference, Jun-06-2024 09:40 AM	06/06
Transcript : Veeva Systems Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 02:00 PM	06/06
Citigroup Adjusts Veeva Systems Price Target to $256 From $274, Maintains Buy Rating	03/06	MT
Stifel Nicolaus Adjusts Veeva Systems Price Target to $210 From $250, Maintains Buy Rating	31/05	MT
Evercore ISI Cuts Price Target on Veeva Systems to $200 From $230, Maintains In-Line Rating	31/05	MT
UBS Adjusts Veeva Systems Price Target to $185 From $235, Maintains Neutral Rating	31/05	MT
Baird Adjusts Veeva Systems' Price Target to $245 From $255, Maintains Outperform Rating	31/05	MT
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	31/05	MT
Piper Sandler Cuts Price Target on Veeva Systems to $235 From $245, Maintains Overweight Rating	31/05	MT
Morgan Stanley Cuts Price Target on Veeva Systems to $173 From $210, Says Billings 'Continue to Disappoint,' Keeps Underweight Rating	31/05	MT
Veeva Systems Fiscal Q1 Non-GAAP Earnings, Sales Rise But Full-Year Revenue Guidance Cut; Shares Fall Premarket	31/05	MT
Veeva Systems Fiscal Q1 Non-GAAP EPS, Revenue Rise; FY 2025 Revenue Guidance Cut; Shares Fall After Hour	31/05	MT
Transcript : Veeva Systems Inc., Q1 2025 Earnings Call, May 30, 2024	31/05
Earnings Flash (VEEV) VEEVA SYSTEMS Reports Q1 EPS $1.50, vs. Street Est of $1.43	31/05	MT
Earnings Flash (VEEV) VEEVA SYSTEMS Posts Q1 Revenue $650.3M, vs. Street Est of $642M	31/05	MT
Veeva Systems Inc. Provides Earnings Guidance for the Second Quarter Ending July 31, 2024 and for the Fiscal Year Ending January 31, 2025	31/05	CI
Veeva Systems Guides For FY 2025 EPS of $6.16 on Revenue of $2.70-$2.71 Billion, vs CIQ Analyst Consensus of $6.15/Share on Revenue of $2.73 Billion	31/05	MT
Veeva Systems Guides For Q2 EPS of $1.53-$1.54 on Revenue of $666-$669 Million, vs CIQ Analyst Consensus of $1.52/Share on Revenue of $675 Million	31/05	MT
Veeva Systems Reports Q1 EPS of $1.50 on Revenue of $650 Million, vs CIQ Analyst Consensus of $1.42/Share on Revenue of $642 Million	31/05	MT
Veeva Systems Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	31/05	CI
Hangzhou Tigermed Consulting Co., Ltd. Selects Veeva Vault EDC as Technology Foundation for Modern Electronic Data Capture	30/05	CI
Baird Raises Price Target on Veeva Systems to $255 From $251, Maintains Outperform Rating	29/05	MT

Chart Veeva Systems Inc.

Duration

Period

More charts

Company Profile

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Sector

Advanced Medical Equipment & Technology

Calendar

28/08/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Veeva Systems Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

183 USD

Average target price

222.3 USD

Spread / Average Target

+21.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	-4.94%	29.93B
PRO MEDICUS LIMITED	+49.49%	9.7B
SECTRA AB	+34.36%	4.42B
EVOLENT HEALTH, INC.	-42.11%	2.3B
VERADIGM INC.	-9.44%	1.52B
OMNICELL, INC.	-28.06%	1.21B
LUNIT INC.	-42.92%	967M
SIMULATIONS PLUS, INC.	+8.65%	957M
B-SOFT CO.,LTD.	-47.18%	746M
ENTERO HEALTHCARE SOLUTIONS LIMITED	0.00%	549M

Medical Software & Technology Services